Nootropil 800mg: Advanced Cognitive Support for Brain Health
| Product dosage: 800mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $1.11 | $66.55 (0%) | 🛒 Add to cart |
| 90 | $1.08 | $99.83 $96.80 (3%) | 🛒 Add to cart |
| 120 | $1.05 | $133.10 $126.04 (5%) | 🛒 Add to cart |
| 180 | $1.03 | $199.65 $185.54 (7%) | 🛒 Add to cart |
| 270 | $1.02 | $299.48 $275.28 (8%) | 🛒 Add to cart |
| 360 | $1.02
Best per pill | $399.30 $366.03 (8%) | 🛒 Add to cart |
Synonyms
| |||
Nootropil is a well-established nootropic medication, with the active ingredient Piracetam, designed to support and enhance cognitive function. As a member of the racetam family, it operates by modulating neurotransmission and improving neuronal membrane fluidity, which is critical for efficient synaptic communication. It is primarily indicated for the management of cortical myoclonus and as adjunctive therapy for a range of cognitive disorders. This product card provides a comprehensive, evidence-based overview for healthcare professionals considering its therapeutic application.
Features
- Active ingredient: Piracetam 800mg per tablet
- Pharmaceutical form: Film-coated tablets for oral administration
- Mechanism of action: Modulates glutamate and acetylcholine receptors; enhances neuronal membrane plasticity
- Bioavailability: Nearly 100% following oral administration
- Half-life: Approximately 5 hours in plasma
- Excretion: Primarily renal, unchanged
- Prescription status: Available by prescription in most jurisdictions
Benefits
- Enhances learning capacity and memory retention through improved synaptic plasticity.
- Supports cognitive recovery in patients with post-stroke aphasia and related cerebrovascular conditions.
- Reduces the frequency and severity of cortical myoclonus episodes.
- Improves neuronal metabolism and oxygen utilization, supporting overall brain energy efficiency.
- May aid in neuroprotection by mitigating excitotoxic damage and oxidative stress.
- Facilitates interhemispheric communication, potentially benefiting integrative brain functions.
Common use
Nootropil is clinically employed for the management of cortical myoclonus, either as monotherapy or in combination with other anticonvulsants. It is also utilized as an adjunctive treatment in cognitive disorders secondary to cerebrovascular accidents, such as post-stroke aphasia, dizziness, and vertigo. Off-label, it is sometimes used in age-related cognitive decline, dyslexia, and sickle cell anemia-related vaso-occlusive complications, though evidence supporting these uses varies. Its application is always under specialist supervision, with treatment tailored to individual patient profiles and response.
Dosage and direction
Dosage must be individualized based on indication, renal function, and patient response. For cortical myoclonus, initial dosing is typically 7.2 g/day, divided into two or three doses, increasing by 4.8 g/day every three to four days up to a maximum of 24 g/day. Maintenance doses are generally between 4.8–24 g/day. For cognitive disorders, common dosages range from 2.4–4.8 g/day. Tablets should be taken with water, with or without food, though administration with meals may reduce gastrointestinal discomfort. Dosage adjustment is necessary in patients with renal impairment. Treatment should not be discontinued abruptly.
Precautions
Use with caution in patients with a history of hemorrhagic diathesis or those undergoing surgical procedures, due to potential effects on platelet aggregation. Renal function should be assessed before and during treatment, especially in elderly patients. Hepatic impairment requires careful monitoring, although piracetam is not extensively metabolized. There is limited data on use during pregnancy and lactation; use only if potential benefit justifies potential risk. Patients should avoid activities requiring mental alertness, such as driving, until their response to the medication is known. Regular hematological and biochemical monitoring is advised during long-term therapy.
Contraindications
Nootropil is contraindicated in patients with known hypersensitivity to piracetam or any excipients in the formulation. It is also contraindicated in those with severe renal impairment (creatinine clearance <20 mL/min) and in patients with cerebral hemorrhage. It should not be used in individuals with Huntington’s chorea, due to the theoretical risk of exacerbating choreiform movements. Use is prohibited in patients with major psychiatric disorders without specialist oversight.
Possible side effect
Most adverse reactions are dose-dependent and reversible upon dose reduction or discontinuation. Common side effects include nervousness, weight gain, somnolence, depression, and asthenia. Gastrointestinal disturbances such as nausea, vomiting, abdominal pain, and diarrhea may occur. Less frequently, patients may experience dizziness, headache, insomnia, agitation, or anxiety. Rare but serious side effects include severe dermatological reactions, thrombophlebitis, and exacerbation of epilepsy in predisposed individuals. Any unusual neurological or psychiatric symptoms should be promptly evaluated.
Drug interaction
Piracetam may potentiate the effects of central nervous system depressants, including alcohol, benzodiazepines, and barbiturates. Concurrent use with anticoagulants or antiplatelet agents may increase bleeding risk. It might interact with thyroid hormones and drugs affecting renal function. Co-administration with other nootropics or psychostimulants should be monitored for additive effects. Always review the patient’s full medication list to anticipate and manage potential interactions.
Missed dose
If a dose is missed, it should be taken as soon as remembered, unless it is almost time for the next dose. In that case, skip the missed dose and resume the regular dosing schedule. Do not double the dose to catch up. Consistent dosing is important to maintain stable plasma levels, particularly for anticonvulsant effects. Patients should be advised to set reminders to support adherence.
Overdose
Symptoms of overdose may include diarrhea, abdominal pain, and pronounced lethargy or agitation. In severe cases, hematological abnormalities or neurological symptoms could occur. There is no specific antidote; treatment is supportive and symptomatic. Gastric lavage may be considered if ingestion was recent. Hemodialysis can remove piracetam effectively due to its low molecular weight and minimal protein binding. Patients should seek immediate medical attention if overdose is suspected.
Storage
Store at room temperature (15–30°C), in a dry place, protected from light and moisture. Keep the container tightly closed. Do not freeze. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging. Proper storage ensures stability and efficacy throughout the shelf life.
Disclaimer
This information is intended for healthcare professionals and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read in this product card. Dosage and indications may vary by region; always follow local prescribing guidelines.
Reviews
Clinical studies and meta-analyses generally support the efficacy of piracetam in cortical myoclonus and post-stroke cognitive recovery, though evidence for other uses is more mixed. Specialist consensus emphasizes its value in specific neurological populations, with a favorable safety profile in appropriate doses. Patient-reported outcomes often note improvements in clarity of thought and memory, though individual responses vary. Long-term adherence is high in responsive patients, underlining its utility in managed therapeutic contexts.